Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma

NCT06922604 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Primary Central Nervous System Lymphoma
Secondary Central Nervous System Lymphoma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Glofitamab
PROCEDURE: Lumbar Puncture
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Obinutuzumab
PROCEDURE: Positron Emission Tomography

Sponsor

City of Hope Medical Center

Collaborators

[object Object]